Xin L. Yan
Nanjing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
BLAST demonstrates higher prognostic accuracy for survival than CPSS in Chinese patients with chronic myelomonocytic leukemia.
Journal: Blood cancer journal
Published: February 15, 2026
Comparative Analysis of ICC and WHO Classifications Reveals Molecular and Clinical Convergence Between AML-MR and MDS/AML.
Journal: Hematological oncology
Published: August 10, 2025
Blowfly-derived mammal DNA as mammal diversity assessment tool: Determination of dispersal activity and flight range of tropical blowflies.
Journal: Biodiversity data journal
Published: June 21, 2023
Non-driver mutations landscape in different stages of primary myelofibrosis determined ASXL1 mutations play a critical role in disease progression.
Journal: Blood cancer journal
Published: January 31, 2023
Impact of the International Consensus Classification of myelodysplastic syndromes.
Journal: British journal of haematology
Published: October 21, 2022
Distinguishing myelodysplastic syndromes with moderate-to-severe bone marrow fibrosis from triple-negative primary myelofibrosis based on clinical and genetic covariates.
Journal: Hematological oncology
Published: October 20, 2022
Comparison of the revised 4th (2016) and 5th (2022) editions of the World Health Organization classification of myelodysplastic neoplasms.
Journal: Leukemia
Published: July 21, 2022
ASXL1 mutations accelerate bone marrow fibrosis via EGR1-TNFA axis-mediated neoplastic fibrocyte generation in myeloproliferative neoplasms.
Journal: Haematologica
Published: November 07, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026